September 20, 2023 – Page 2

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.21 per Share for Q3 2023

Written by Customer Service on September 20, 2023. Posted in Dividend Reports And Estimates.

HOUSTON, Sept. 20, 2023 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today a quarterly distribution of $0.21 per share for the fiscal quarter ended August 31, 2023. This distribution is payable to common stockholders on October 10, 2023 (as outlined in the table below). Ex-Date Record Date Payment Date DistributionAmount Return of CapitalEstimate(1) 9/29/23 10/2/23 10/10/23 $0.21 10% (1) This estimate is based on the Company’s anticipated earnings and profits. The final determination of the tax character of distributions will not be determinable until after the end of the fiscal year and may differ substantially from this preliminary information. Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE: KYN) is a non-diversified, closed-end...

Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to October 13, 2023

Written by Customer Service on September 20, 2023. Posted in Public Companies.

Dallas, Texas, Sept. 20, 2023 (GLOBE NEWSWIRE) — Broad Capital Acquisition Corp. (the “Company”) (NASDAQ: BRAC, BRACR, BRACU), a special purpose acquisition company formed by Broad Capital LLC, today announced that on September 19, 2023 it caused to be deposited $150,000 (the “Extension Payment”) into the Company’s trust account for its public stockholders, representing $0.0332 per public share, allowing the Company to extend the period of time it has to consummate its initial business combination to October 13, 2023 (the “Monthly Extension”). The Monthly Extension is the ninth of the twelve monthly extensions permitted under the Company’s governing documents. Business Combination On January 18, 2023, the Company entered into a definitive Agreement and Plan of Merger and Business Combination Agreement (the “Business Combination...

Hawthorn Bancshares, Inc. Names New Chief Financial Officer

Written by Customer Service on September 20, 2023. Posted in Public Companies.

JEFFERSON CITY, Mo., Sept. 20, 2023 (GLOBE NEWSWIRE) — Hawthorn Bancshares, Inc. (NASDAQ: HWBK) and its subsidiary Hawthorn Bank announced today that Christopher Hafner will be named Senior Vice President and Chief Financial Officer of both entities effective October 13, 2023, replacing Steve Guthrie who retired from the position on September 1, 2023. A 34-year industry veteran, Hafner has previously held the roles of Chief Accounting Officer at CrossFirst Bank, Chief Financial Officer at each of Missouri Bank and First National Bank of Kansas, Assistant Controller at Commerce Bancshares, Inc. and also previously served in various roles in the audit practice of a public accounting firm. “I am delighted to welcome Chris to the executive team and I’m confident he will play an important role in the future success of our company,”...

CVB Financial Corp. Announces 136th Consecutive Cash Dividend

Written by Customer Service on September 20, 2023. Posted in Dividend Reports And Estimates.

ONTARIO, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the third quarter of 2023. This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on September 20, 2023. The quarterly dividend will be payable on or about October 19, 2023 to shareholders of record as of October 4, 2023. “We are pleased to announce our 136th consecutive cash dividend paid to our shareholders,” said David A. Brager, President and Chief Executive Officer. Corporate Overview CVB Financial Corp. (“CVBF”) is the holding company for Citizens Business Bank. CVBF is one of the 10 largest bank holding companies headquartered in California with over $16 billion in total assets. Citizens Business Bank is consistently...

Borqs Technologies Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

Written by Customer Service on September 20, 2023. Posted in Public Companies.

SANTA CLARA, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”, or the “Company”), a global provider of 5G wireless and Internet of Things (IoT) solutions, today announced that the Company received a deficiency notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) on September 15, 2023, notifying the Company that the Company’s listed securities did not maintain a minimum market value of $35 million (“MVLS”) for a period of 30 consecutive business days to meet the MVLS requirement. In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided a compliance period of 180 calendar days, or until March 13, 2024, to regain compliance. Nasdaq will close the matter and provide written confirmation that the Company has achieved compliance with rule 5550(b)(2) if at...

Gaming and Leisure Properties, Inc. Mourns the Loss of Board Member JoAnne A. Epps

Written by Customer Service on September 20, 2023. Posted in Public Companies.

WYOMISSING, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) – mourns the loss of board member, JoAnne A. Epps, who passed away suddenly on Tuesday, September 19th. JoAnne joined the Board of Directors in September 2021, providing invaluable counsel to the management team throughout her tenure as a Board member. She was serving as Acting President of Temple University at the time of her passing and spent nearly 40 years serving the university and its community. Gaming and Leisure Properties Chairman and Chief Executive Officer, Peter M. Carlino, stated, “We are deeply saddened by the passing of our friend and fellow board member, JoAnne Epps. It was a privilege for me and my fellow Board members to have worked alongside JoAnne. We will be forever grateful for her dedication and service...

Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera

Written by Customer Service on September 20, 2023. Posted in Public Companies.

WATERTOWN, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to MWTX-003 for the treatment of patients with polycythemia vera (PV). “We are delighted to have received Fast Track designation for MWTX-003, which highlights the unmet need for PV patients and the potential of MWTX-003 in a disease where there are few treatment options,” said John Quisel, J.D., Ph.D., President and Chief Executive Officer of Disc. “We believe MWTX-003 is uniquely positioned to address the needs of PV patients and are excited to initiate a...

ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference

Written by Customer Service on September 20, 2023. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in a fireside chat at the 2023 Cantor Global Healthcare Conference on Thursday, September 28, 2023, at 8:00 a.m. ET. A live webcast of the discussion will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcast will be available for 90 days following the events. About ORIC Pharmaceuticals, Inc. ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-114,...

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

Written by Customer Service on September 20, 2023. Posted in Public Companies.

Full commercial launch of NexoBrid marks important first step to becoming the new standard of care for eschar removal in patients with deep partial- and/or full- thickness thermal burns NexoBrid launch significantly expands the total addressable market for Vericel Burn Care CAMBRIDGE, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the U.S. commercial availability of NexoBrid® (anacaulase-bcdb) for the removal of eschar in adults with deep partial- and/or full-thickness thermal burns. Eschar removal is a critical first step in the treatment of burns as it can reduce inflammation, stop burn progression, as well as mitigate infections and sepsis. Surgical excision, which is the current standard of care...

Clover Health to Host Virtual Clover Assistant Showcase on October 12, 2023

Written by Customer Service on September 20, 2023. Posted in Public Companies.

FRANKLIN, Tenn., Sept. 20, 2023 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will host a virtual Clover Assistant Showcase on Thursday, October 12, 2023 at 12:00 p.m. Eastern Time. The event will feature informative product demonstrations, followed by a live Q&A session with Clover executives and key members of the Clover Assistant team. “Healthcare is at a pivotal moment, and Clover Assistant is our answer to the challenges we face,” said Andrew Toy, Chief Executive Officer of Clover Health. “Software-assisted doctors focusing on the early detection of disease aren’t just a nice-to-have; they’re critical....

Day: September 20, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice